Manatuck Hill Partners’s Cogentix Medical, Inc. CGNT Stock Holding History

Manatuck Hill Partners’s Portfolio CGNT Stock Details CGNT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-300,000	Closed	-$1.16M	–	116
2018 Q1	$1.16M	Hold	300,000	–	–	0.61%	44
2017 Q4	$945K	Hold	300,000	–	–	0.49%	46
2017 Q3	$768K	Buy	300,000 +150,000	+100%	+$329K	0.38%	53
2017 Q2	$261K	Hold	150,000	–	–	0.13%	68
2017 Q1	$270K	Buy	150,000 +25,000	+20%	+$49.4K	0.12%	74
2016 Q4	$251K	Buy	+125,000	New	+$255K	0.12%	75

Manatuck Hill Partners's CGNT Position: Q2 2018 in Review

Manatuck Hill Partners sold out of Cogentix Medical, Inc. (CGNT) in Q2 2018, closing a stake of 300,000 shares — an estimated $1.16M sold.

Manatuck Hill Partners first reported a position in CGNT in Q4 2016 and held it in 6 quarters. The position peaked at $1.16M in Q1 2018. 0 funds tracked by Wall St. Rank hold CGNT as of Q2 2018.

Manatuck Hill Partners reported no remaining Cogentix Medical, Inc. position as of Q2 2018 after selling out during the quarter.
Manatuck Hill Partners sold 300,000 Cogentix Medical, Inc. shares in Q2 2018, an estimated $1.16M.
Manatuck Hill Partners first reported a position in Cogentix Medical, Inc. in Q4 2016 and held it in 6 quarters.
Manatuck Hill Partners's Cogentix Medical, Inc. position peaked at $1.16M in Q1 2018.
0 funds tracked by Wall St. Rank held Cogentix Medical, Inc. as of Q2 2018.

Based on Manatuck Hill Partners's 13F filing for Q2 2018, filed 14 Aug 2018.